A detailed history of Sphera Funds Management Ltd. transactions in Chemomab Therapeutics Ltd. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 1,214,575 shares of CMMB stock, worth $2.04 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
1,214,575
Holding current value
$2.04 Million
% of portfolio
0.35%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.93 - $2.46 $1.13 Million - $2.99 Million
1,214,575 New
1,214,575 $1.91 Million

Others Institutions Holding CMMB

About Chemomab Therapeutics Ltd.


  • Ticker CMMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,431,700
  • Market Cap $19.2M
  • Description
  • Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...
More about CMMB
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.